• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[降血脂制剂对冠状动脉粥样硬化的疗效评估]

[Evaluation of the effectiveness of hypolipidemic preparations in coronary arteriosclerosis].

作者信息

Bobkova V I, Lokshina L I, Sidakova M M, Tananova G V, Fomchenkov S I

出版信息

Kardiologiia. 1984 Sep;24(9):54-7.

PMID:6521249
Abstract

Hypolipidemic therapy should be developed as a therapy aimed at the normalization of metabolism since the functional relationship of lipid and carbohydrate metabolism is evident both in normal and pathological conditions. The results of the reaction of the lipid spectrum of the blood to a single glucose load confirms that patients with combined hyperlipoproteinemias (IIb type) are heterogeneous in terms of the pathogenesis of the metabolic disturbances which should be taken into account in assessing the efficiency of hypolipidemic drugs as well as in selecting and administering medicines.

摘要

由于脂质和碳水化合物代谢的功能关系在正常和病理状态下都很明显,降血脂治疗应发展成为一种旨在使代谢正常化的疗法。血液脂质谱对单次葡萄糖负荷反应的结果证实,合并高脂蛋白血症(IIb型)患者在代谢紊乱的发病机制方面存在异质性,这在评估降血脂药物的疗效以及选择和使用药物时都应予以考虑。

相似文献

1
[Evaluation of the effectiveness of hypolipidemic preparations in coronary arteriosclerosis].[降血脂制剂对冠状动脉粥样硬化的疗效评估]
Kardiologiia. 1984 Sep;24(9):54-7.
2
The hyperlipoproteinemias.
Med Clin North Am. 1989 Jul;73(4):859-93. doi: 10.1016/s0025-7125(16)30643-5.
3
[The use of Enduracin--a prolonged-action form of nicotinic acid--in correcting atherogenic dyslipidemias].[使用恩杜拉辛(烟酸长效制剂)纠正致动脉粥样硬化血脂异常]
Kardiologiia. 1993;33(10):54-9, 6.
4
[Clinical research on the hypolipidemic action of a probucol preparation].[普罗布考制剂降血脂作用的临床研究]
Vutr Boles. 1986;25(2):73-7.
5
[The effectiveness of the hypolipemic preparation lovastatin in patients with ischemic heart disease and hyperlipoproteinemia].
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1989;12(2):71-4.
6
[Effect of probucol on lipid metabolism and the clinical course of ischemic heart disease and arteriosclerosis obliterans of the vessels of the lower extremities].普罗布考对脂质代谢及缺血性心脏病和下肢血管闭塞性动脉硬化临床病程的影响
Kardiologiia. 1984 Jun;24(6):76-9.
7
[A comparison of the hypolipidemic action of probucol at doses of 500 and 1000 mg/day in moderate hyperlipoproteinemia].[普罗布考500毫克/天和1000毫克/天剂量对中度高脂蛋白血症的降血脂作用比较]
Ter Arkh. 1998;70(8):17-21.
8
[Discrimination between the effects of hypolipidemic and antiatherogenic drugs: probucol pharmacokinetics (review of the literature)].[降血脂药物与抗动脉粥样硬化药物作用的鉴别:普罗布考的药代动力学(文献综述)]
Klin Lab Diagn. 2000 Aug(8):3-9.
9
What kinds of studies should be required to probe efficacy and safety of drugs in special populations?需要开展哪些类型的研究来探究药物在特殊人群中的疗效和安全性?
Am J Cardiol. 1998 Apr 23;81(8A):84F-87F.
10
Hyperlipoproteinemias: part IV. Drug regimens.高脂蛋白血症:第四部分。药物治疗方案。
S D J Med. 1991 May;44(5):117-20.